4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-029337
Director sold 1,666 shares at an average $62.15 ($103,538)
From the SEC's structured data for this filing
Trades in this filing
SATO VICKI L · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-04-28 | Sale : show line 1 in the form | −381 | $60.71 | $23,129 | 137,040 | D |
| 2021-04-28 | Sale : show line 2 in the form | −597 | $62.05 | $37,042 | 136,443 | D |
| 2021-04-28 | Sale : show line 3 in the form | −688 | $63.03 | $43,367 | 135,755 | D |
| Open-market sales · 1,666 sh · avg $62.15 · $103,538 | ||||||
Loading xslF345X03/doc4.xml…